Genetic Test Offers New Breakthrough in Cancer Screening

American researchers have developed a bloodbiomarker levels initially declined and then rose
test that can detect whether a patient's canceragain, suggesting cancer reoccurrence.
has spread or reoccurred. The test is customizedWhile the rest remains costly and in its initial
based on an individual's genetic mapping, making itstages as of now, medical researchers are
an exciting new innovation in the world of cancerhopeful that they can develop the test to
treatment.eventually detect cancerous tumors before they
In a study recently published in the Sciencegrow too large. They also hope to reduce the
Translational Medicine journal, researchers firstcost of the test as they refine the technology.
examined the DNA of normal and cancerousIn the near future, such genetic testing might
tissues from several patients with different typesoffer new hope for cancer patients. It is
of cancer. Next, they looked for signals ofremarkable that such a blood test, which was
tumors, such as extra copies of DNA or fusedunthinkable before the mapping of DNA, could be
chromosomes, in their genetic sequence. If suchdeveloped and implemented for cancer treatment
markers were found, then they examined theand possibly prevention. Indeed, it appears that
patient's blood to look for cancer remnants,testing of genetic codes can tell us more than
finding them in two out of six cancer patients.ever thought possible and hopefully lead to new
The researchers tested again after the cancerbreak through in the fight of cancer.
had been removed from these patients. Genetic